Related Experiment Video
Updated: May 16, 2026
15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
Resentment, hate, and hope in amyotrophic lateral sclerosis
Frontiers in Psychology
|December 4, 2012
Summary
People with Amyotrophic Lateral Sclerosis (ALS) report high hope, especially those married or with longer diagnoses. Anger and resentment levels varied, suggesting psychological factors like hope are crucial in ALS patient care.
Area of Science:
- Neuroscience
- Psychology
- Oncology
Background:
- Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease.
- Psychological aspects of ALS are researched, but anger, resentment, and hope remain understudied.
- Understanding patient psychological states is vital for comprehensive care.
Purpose of the Study:
- To investigate anger, resentment, and hope in individuals with ALS.
- To explore the relationship between these emotions and the willingness to adopt a nutrient-dense diet for longevity.
- To identify factors influencing hope, anger, and resentment in the ALS population.
Main Methods:
- An online survey was administered to individuals diagnosed with ALS.
- The survey assessed levels of hope, hate, and resentment.
- Data were analyzed in relation to disease duration, marital status, gender, and dietary intentions.
Main Results:
- A high level of hope was observed among participants.
- Longer disease duration and being married correlated with higher hope and lower hate.
- Resentment and hate were higher in those recently diagnosed and in women; dietary choices linked to hope.
Conclusions:
- Hope is a significant factor for individuals living with ALS.
- Anger and resentment may be more pronounced in earlier disease stages and in women.
- Future research should explore the roles of hope, hate, and resentment in ALS patient management and treatment adherence.
More Related Videos
10:49Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
08:59Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
Related Concept Videos
01:26Cross-bridge Cycle
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...